These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23239591)

  • 1. Newborn screening and cascade testing for FMR1 mutations.
    Sorensen PL; Gane LW; Yarborough M; Hagerman RJ; Tassone F
    Am J Med Genet A; 2013 Jan; 161A(1):59-69. PubMed ID: 23239591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn, carrier, and early childhood screening recommendations for fragile X.
    Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
    Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for fragile X syndrome.
    Tassone F
    JAMA Neurol; 2014 Mar; 71(3):355-9. PubMed ID: 24395328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.
    McConkie-Rosell A; Abrams L; Finucane B; Cronister A; Gane LW; Coffey SM; Sherman S; Nelson LM; Berry-Kravis E; Hessl D; Chiu S; Street N; Vatave A; Hagerman RJ
    J Genet Couns; 2007 Oct; 16(5):593-606. PubMed ID: 17497108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental and behavioral pediatricians' attitudes toward screening for fragile X.
    Acharya K; Schindler A
    Am J Intellect Dev Disabil; 2013 Jul; 118(4):284-93. PubMed ID: 23937370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the national society of genetic counselors.
    Finucane B; Abrams L; Cronister A; Archibald AD; Bennett RL; McConkie-Rosell A
    J Genet Couns; 2012 Dec; 21(6):752-60. PubMed ID: 22797890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of screening strategies for fragile X syndrome in the UK.
    Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
    Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fragile X chromosomes and fragile X syndrome].
    Boonen SE; Grønskov K; Brøndum-Nielsen K
    Ugeskr Laeger; 2006 Oct; 168(43):3727-8. PubMed ID: 17069739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X Newborn Screening: Lessons Learned From a Multisite Screening Study.
    Bailey DB; Berry-Kravis E; Gane LW; Guarda S; Hagerman R; Powell CM; Tassone F; Wheeler A
    Pediatrics; 2017 Jun; 139(Suppl 3):S216-S225. PubMed ID: 28814542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple molecular diagnostic method for fragile X syndrome in Egyptian patients: pilot study.
    Meguid NA; Ismail MF; El-Mahdy RS; Barakat MA; El-Awady MK
    Acta Biochim Pol; 2014; 61(2):259-63. PubMed ID: 24936518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
    Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
    Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for fragile X syndrome in males from specialized institutions in the northeast region of Brazil.
    Viveiros MT; Santos MD; Dos Santos JM; Viveiros DM; Cavalcante MR; Caldas AJ; Pimentel MM
    Genet Mol Res; 2015 Jun; 14(2):6897-905. PubMed ID: 26125897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for fragile X gene mutations throughout the life span.
    Hagerman RJ; Hagerman PJ
    JAMA; 2008 Nov; 300(20):2419-21. PubMed ID: 19033593
    [No Abstract]   [Full Text] [Related]  

  • 16. FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.
    Santa María L; Aliaga S; Faundes V; Morales P; Pugin Á; Curotto B; Soto P; Peña MI; Salas I; Alliende MA
    Genet Res (Camb); 2016 Jun; 98():e11. PubMed ID: 27350105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health problems in females carriers of premutation in the FMR1 gene.
    Lisik MZ
    Psychiatr Pol; 2017 Oct; 51(5):899-907. PubMed ID: 29289969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular testing for Fragile X Syndrome: lessons learned from 119,232 tests performed in a clinical laboratory.
    Strom CM; Crossley B; Redman JB; Buller A; Quan F; Peng M; McGinnis M; Fenwick RG; Sun W
    Genet Med; 2007 Jan; 9(1):46-51. PubMed ID: 17224689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of the
    Wheeler A; Raspa M; Hagerman R; Mailick M; Riley C
    Pediatrics; 2017 Jun; 139(Suppl 3):S172-S182. PubMed ID: 28814538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature ovarian failure and FMR1 gene mutations: an update.
    Conway GS
    Ann Endocrinol (Paris); 2010 May; 71(3):215-7. PubMed ID: 20398889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.